1,3-Benzenediol, 5-[(1Z)-2-(4-hydroxyphenyl)ethenyl]-
Internal ID | 800a025e-60c8-4cca-8ef2-2e2edb64b90f |
Taxonomy | Phenylpropanoids and polyketides > Stilbenes |
IUPAC Name | 5-[2-(4-hydroxyphenyl)ethenyl]benzene-1,3-diol |
SMILES (Canonical) | C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O |
SMILES (Isomeric) | C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O |
InChI | InChI=1S/C14H12O3/c15-12-5-3-10(4-6-12)1-2-11-7-13(16)9-14(17)8-11/h1-9,15-17H |
InChI Key | LUKBXSAWLPMMSZ-UHFFFAOYSA-N |
Popularity | 5,414 references in papers |
Molecular Formula | C14H12O3 |
Molecular Weight | 228.24 g/mol |
Exact Mass | 228.078644241 g/mol |
Topological Polar Surface Area (TPSA) | 60.70 Ų |
XlogP | 3.10 |
Atomic LogP (AlogP) | 2.97 |
H-Bond Acceptor | 3 |
H-Bond Donor | 3 |
Rotatable Bonds | 2 |
(resveratrol) |
MFCD00133799 |
Resveravine(R) |
1,3-Benzenediol, 5-[2-(4-hydroxyphenyl)ethenyl]- |
Spectrum_001148 |
SpecPlus_000391 |
(Cis-Trans)-Resveratrol |
Prestwick0_000508 |
Prestwick1_000508 |
Spectrum2_001497 |
There are more than 10 synonyms. If you wish to see them all click here. |
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
Human Intestinal Absorption | + | 0.9884 | 98.84% |
Caco-2 | + | 0.8398 | 83.98% |
Blood Brain Barrier | - | 0.6500 | 65.00% |
Human oral bioavailability | - | 0.6857 | 68.57% |
Subcellular localzation | Mitochondria | 0.6615 | 66.15% |
OATP2B1 inhibitior | - | 0.7145 | 71.45% |
OATP1B1 inhibitior | + | 0.9414 | 94.14% |
OATP1B3 inhibitior | + | 0.9479 | 94.79% |
MATE1 inhibitior | - | 0.9800 | 98.00% |
OCT2 inhibitior | - | 0.9088 | 90.88% |
BSEP inhibitior | - | 0.6594 | 65.94% |
P-glycoprotein inhibitior | - | 0.9537 | 95.37% |
P-glycoprotein substrate | - | 0.9899 | 98.99% |
CYP3A4 substrate | - | 0.7342 | 73.42% |
CYP2C9 substrate | - | 0.5955 | 59.55% |
CYP2D6 substrate | - | 0.6927 | 69.27% |
CYP3A4 inhibition | + | 0.7539 | 75.39% |
CYP2C9 inhibition | + | 0.7068 | 70.68% |
CYP2C19 inhibition | + | 0.8052 | 80.52% |
CYP2D6 inhibition | - | 0.9226 | 92.26% |
CYP1A2 inhibition | + | 0.9106 | 91.06% |
CYP2C8 inhibition | + | 0.4709 | 47.09% |
CYP inhibitory promiscuity | + | 0.8559 | 85.59% |
UGT catelyzed | + | 0.7000 | 70.00% |
Carcinogenicity (binary) | - | 0.6496 | 64.96% |
Carcinogenicity (trinary) | Non-required | 0.5753 | 57.53% |
Eye corrosion | - | 0.9581 | 95.81% |
Eye irritation | + | 0.9960 | 99.60% |
Skin irritation | + | 0.6257 | 62.57% |
Skin corrosion | - | 0.7751 | 77.51% |
Ames mutagenesis | - | 0.7600 | 76.00% |
Human Ether-a-go-go-Related Gene inhibition | - | 0.8361 | 83.61% |
Micronuclear | - | 0.5900 | 59.00% |
Hepatotoxicity | - | 0.6060 | 60.60% |
skin sensitisation | + | 0.8871 | 88.71% |
Respiratory toxicity | - | 0.8111 | 81.11% |
Reproductive toxicity | - | 0.5556 | 55.56% |
Mitochondrial toxicity | - | 0.8125 | 81.25% |
Nephrotoxicity | + | 0.5376 | 53.76% |
Acute Oral Toxicity (c) | III | 0.6825 | 68.25% |
Estrogen receptor binding | + | 0.9144 | 91.44% |
Androgen receptor binding | + | 0.7659 | 76.59% |
Thyroid receptor binding | + | 0.7160 | 71.60% |
Glucocorticoid receptor binding | + | 0.7722 | 77.22% |
Aromatase binding | + | 0.9242 | 92.42% |
PPAR gamma | + | 0.9289 | 92.89% |
Honey bee toxicity | - | 0.8722 | 87.22% |
Biodegradation | - | 0.8750 | 87.50% |
Crustacea aquatic toxicity | + | 0.5600 | 56.00% |
Fish aquatic toxicity | + | 0.9588 | 95.88% |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
CHEMBL261 | P00915 | Carbonic anhydrase I |
2180 nM |
Ki |
PMID: 22487176
|
CHEMBL205 | P00918 | Carbonic anhydrase II |
1750 nM |
Ki |
PMID: 22487176
|
CHEMBL2885 | P07451 | Carbonic anhydrase III |
6750 nM |
Ki |
PMID: 22487176
|
CHEMBL3729 | P22748 | Carbonic anhydrase IV |
4010 nM |
Ki |
PMID: 22487176
|
CHEMBL3594 | Q16790 | Carbonic anhydrase IX |
810 nM 9530 nM |
Ki Ki |
via Super-PRED
PMID: 22487176 |
CHEMBL4789 | P35218 | Carbonic anhydrase VA |
2860 nM |
Ki |
PMID: 22487176
|
CHEMBL3969 | Q9Y2D0 | Carbonic anhydrase VB |
3240 nM |
Ki |
PMID: 22487176
|
CHEMBL3025 | P23280 | Carbonic anhydrase VI |
8630 nM |
Ki |
PMID: 22487176
|
CHEMBL2326 | P43166 | Carbonic anhydrase VII |
8980 nM |
Ki |
PMID: 22487176
|
CHEMBL3242 | O43570 | Carbonic anhydrase XII |
8130 nM 950 nM |
Ki Ki |
PMID: 22487176
via Super-PRED |
CHEMBL3912 | Q8N1Q1 | Carbonic anhydrase XIII |
8250 nM |
Ki |
PMID: 22487176
|
CHEMBL3510 | Q9ULX7 | Carbonic anhydrase XIV |
1950 nM 830 nM |
Ki Ki |
PMID: 22487176
via Super-PRED |
CHEMBL284 | P27487 | Dipeptidyl peptidase IV |
0.6 nM |
IC50 |
via Super-PRED
|
CHEMBL206 | P03372 | Estrogen receptor alpha |
785 nM |
Ki |
via Super-PRED
|
CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit |
250 nM |
IC50 |
via Super-PRED
|
CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit |
500 nM |
IC50 |
via Super-PRED
|
CHEMBL3959 | P16083 | Quinone reductase 2 |
54 nM |
Kd |
via Super-PRED
|
CHEMBL3194 | P02766 | Transthyretin |
470 nM |
Kd |
via Super-PRED
|
CHEMBL1075138 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 |
1 nM |
Potency |
via Super-PRED
|
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 95.52% | 91.11% |
CHEMBL242 | Q92731 | Estrogen receptor beta | 92.49% | 98.35% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 88.38% | 95.56% |
CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 87.44% | 96.00% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 86.66% | 86.33% |
CHEMBL2288 | Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 84.13% | 91.71% |
CHEMBL1951 | P21397 | Monoamine oxidase A | 83.75% | 91.49% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 81.12% | 94.45% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
PubChem | 5056 |
NPASS | NPC275053 |
ChEMBL | CHEMBL2019155 |
LOTUS | LTS0196778 |
wikiData | Q60998680 |